Advertising

CVE:OGI

6.85
0.03 (0.44%) 1d
0
Showing 1 to 15 of 17 entries
BUY
Flies under the radar, not top tier because of its size. Tremendous respect for management team. Very efficient, and that's probably why BATS invested. Will be one of the fastest growing sectors in next decade.
0
HOLD
He has owned it for some time. It will take time for oversupply in the industry to work its way through the market. It is sad for people to be laid off but management needed to take actions for their balance sheet. They should be one of the leaders in the future.
0
BUY
They have been very good at executing. They have a great production facility. Now they are moving into 2.0 products. Over the next two quarters we should see what the sales are like.
0
WATCH
They have done an excellent job executing. They have been working on a number of different products. They have been a leader in Canada and will continue. It will depend what happens with the new products.
0
DON'T BUY
All the cannabis stocks are down 50-80% this year. The legal market in Canada has proven to be a bust as the retails stores have not come online as fast as people would have liked and the margins are not there. He would not recommend buying it here. He would short all these stocks if it were not for the cost of borrowing to short them. He is skeptical about the health claims of CBD.
0
TOP PICK

This trades at low valuations – 12 times earnings. A low cost producer in New Brunswick. Yield 0%. (Analysts’ price target is $9.09)

0
DON'T BUY

Contender, go by the wayside, or be acquired? Be careful, takeout premium is built in. If no takeout, there could be a blow up in the stock. Stuck in no man’s land, no R&D on pharmaceutical side, no export agreements. Tough for them to compete in exports and pharmaceuticals when the market price of wholesale marijuana reaches a plateau in a year or two.

0
PAST TOP PICK

(A Top Pick March 10/17. Up 63%) He says this cannabis producer has done well, but still does not get the recognition it deserves – especially on the east coast.

0
DON'T BUY

(Market Call Minute.) Until proven otherwise, marijuana producers are producing an agricultural commodity and will earn low returns on investment capital. It's a business model that’s unproven, and he would steer clear.

0
COMMENT

Chart shows some pretty big swings. What is positive currently is that there is nice little upward trend, but is probably going to be in jeopardy based on the gravity affect. If it got below $2.70, he would say there is probably something wrong with the story. When you have a new industry like this, you will often get some rationalization, and in this new cycle, he expects it will happen much sooner. It’s really hard to tell which are the winners.

0
BUY

(Market Call Minute) They had all these issues with the recall, but it is probably one of the cheapest ones out there.

0
COMMENT

Marijuana stocks sold off a few days before the legislation was getting tabled. There is a lot of supply of stock coming on right now with a lot of companies going public. After everything they’ve gone through, he still thinks they are one of the best operators, and that the stock is worth more than the current price. Their relationship with TGS out of the US is really interesting, where they are looking at the extracts and other products. That is probably not going to come into play for the company, but certainly down the road with the next step of legalization, it will.

0
COMMENT

Marijuana stocks are tough to get a read on. They’ve all moved in a similar direction. He doesn’t know what the industry is going to look like or what the regulation is going to be like and how everything is going to play out. This is an industry in its infancy, but as a portfolio manager, it is not something he would look at. Once there is some clarification on what future legislation is going to look like, federally and provincially, then it will be a lot easier to determine which stocks are the ones to own.

0
TOP PICK

He likes the prospects and just added to his holdings recently. This will be a core holding in his marijuana fund portfolio. It is the only one in the Maritimes. (Analysts’ price target is $4.10.)

0
COMMENT

This is going to be a massive growing sector. Legislation has not been tabled yet, and all these stocks have been running up on anticipation of the government’s task force reporting later this month. It is probably going to be about nothing, and doesn’t think the public is going to get access to it. You have to watch for when the legislation gets tabled, probably in 2017. Valuations have run up so much they have to be dangerous.

0
Showing 1 to 15 of 17 entries

Organigram Holdings(OGI-X) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Organigram Holdings is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Organigram Holdings(OGI-X) Frequently Asked Questions

What is Organigram Holdings stock symbol?

Organigram Holdings is a Canadian stock, trading under the symbol OGI-X on the TSX Venture Exchange (OGI-CV). It is usually referred to as TSXV:OGI or OGI-X

Is Organigram Holdings a buy or a sell?

In the last year, there was no coverage of Organigram Holdings published on Stockchase.

Is Organigram Holdings a good investment or a top pick?

Organigram Holdings was recommended as a Top Pick by on . Read the latest stock experts ratings for Organigram Holdings.

Why is Organigram Holdings stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Organigram Holdings worth watching?

0 stock analysts on Stockchase covered Organigram Holdings In the last year. It is a trending stock that is worth watching.

What is Organigram Holdings stock price?

On 2019-08-21, Organigram Holdings (OGI-X) stock closed at a price of $6.85.